DAA423 |
vascular endothelial growth factor B |
Molecular |
skeletal muscle |
Human |
VEGFB |
6.0% Decrease Gene Expression Level |
|
DAA517 |
very low density lipoprotein receptor |
Molecular |
skeletal muscle |
Human |
VLDLR |
4.0% Decrease Gene Expression Level |
|
DAA565 |
vesicle transport through interaction with t-SNAREs homolog 1B (yeast) |
Molecular |
skeletal muscle |
Human |
VTI1B |
3.0% Decrease Gene Expression Level |
|
DAA436 |
WD repeat domain 12 |
Molecular |
skeletal muscle |
Human |
WDR12 |
3.0% Decrease Gene Expression Level |
|
DAA826 |
Weaker digestive tract muscle contractions |
Physiological |
alimentary system, smooth muscle |
Human |
— |
— |
|
DAA353 |
xeroderma pigmentosum, complementation group C |
Molecular |
skeletal muscle |
Human |
XPC |
7.0% Increase Gene Expression Level |
|
DAA586 |
xeroderma pigmentosum, complementation group C |
Molecular |
skeletal muscle |
Human |
XPC |
6.0% Increase Gene Expression Level |
|
DAA330 |
zinc finger and BTB domain containing 4 |
Molecular |
skeletal muscle |
Human |
ZBTB4 |
2.0% Increase Gene Expression Level |
|
DAA513 |
zinc finger, FYVE domain containing 20 |
Molecular |
skeletal muscle |
Human |
ZFYVE20 |
3.0% Increase Gene Expression Level |
|
DAA388 |
zinc finger protein 36, C3H type-like 1 |
Molecular |
skeletal muscle |
Human |
ZFP36L1 |
6.0% Increase Gene Expression Level |
|